VSIR and neoplasm: Though a ligand for VISTA has yet to be identified, antibody blockade of this regulatory protein has been shown to enhance the immunostimulatory functions of TIDC and to improve T cell effector function and tumor control in murine models of melanoma and bladder cancer.72